Main Page: Difference between revisions
No edit summary |
|||
(4 intermediate revisions by the same user not shown) | |||
Line 1: | Line 1: | ||
The W8MD' | [[File:W8MD-Team.jpg|800px|left]] | ||
The W8MD' [[W8MD_Weight_Loss,_Sleep_and_Medspa|physician weight loss]] program is a clinically proven, evidence-based program that helps patients [[lose weight]] and maintain the weight with an ongoing maintenance plan for [[medical-weight-loss|adults]] and [[childhood obesity|children]]. [[W8MD_Weight_Loss,_Sleep_and_Medspa|Learn more...]] | |||
==Tirzepatide / Semaglutide for weight loss == | |||
[[Tirzepatide]], available as [[Zepbound]] and [[Mounjaro]], is a weekly injection that helps control blood sugar levels and was approved for use in treating type 2 diabetes by the FDA in May 2022. Distinguished from drugs such as [[Ozempic]] and [[Wegovy]] both of which have [[Semaglutide]], [[Zepbound]], [[Mounjaro]] with active ingredient of [[Tirzepatide]] is a combination of a glucagon-like peptide-1 (GLP-1) receptor agonist, used for diabetes and weight loss treatment, and a glucose-dependent insulinotropic polypeptide (GIP), a hormone that aids insulin release after eating. | |||
Tirzepatide became so popular that it was listed by the FDA as one of nearly 200 drugs experiencing a supply shortage, along with [[Wegovy]], [[Ozempic]] (semaglutide), and [[Trulicity]] (dulaglutide), which are sometimes prescribed for off-label [[weight loss]] use. [[Mounjaro|Learn more...]] | |||
{|style="border-spacing:8px;margin:0px -8px" | {|style="border-spacing:8px;margin:0px -8px" | ||
|class="MainPageBG" style="width:55%;border:1px solid #cef2e4;background-color:#f5fffa;vertical-align:top;color:#000"| | |class="MainPageBG" style="width:55%;border:1px solid #cef2e4;background-color:#f5fffa;vertical-align:top;color:#000"| | ||
Line 6: | Line 12: | ||
<h3 style="margin:0;background:#cedff2;font-size:120%;font-weight:bold;border:1px solid #a3bfb1;text-align:left;color:#000;padding:0.2em 0.4em;"> | <h3 style="margin:0;background:#cedff2;font-size:120%;font-weight:bold;border:1px solid #a3bfb1;text-align:left;color:#000;padding:0.2em 0.4em;"> | ||
[[File:Weight-loss-150.png|left|150px]] | [[File:Weight-loss-150.png|left|150px]] | ||
''' | '''Physician Weight Loss Program''' | ||
* W8MD's [[weight loss]] program has a proven track record of [[weight loss success stories|success]] | * W8MD's [[weight loss]] program has a proven track record of [[weight loss success stories|success]] | ||
* Helped thousands of patients lose weight and keep it off. | * Helped thousands of patients lose weight and keep it off. | ||
Line 25: | Line 31: | ||
If insurance does not cover the brands, W8MD offers discounted '''[[weight loss injections]]''' | If insurance does not cover the brands, W8MD offers discounted '''[[weight loss injections]]''' | ||
===Semaglutide & Tirzepatide: Proven solutions starting at just $125.00 biweekly!=== | ===Semaglutide & Tirzepatide: Proven solutions starting at just $125.00 biweekly!=== | ||
[[Weight loss injections|Learn more...]] | [[Weight loss injections|Learn more...]] | ||
|} | |} | ||
<!-- Start of right-column --> | <!-- Start of right-column --> | ||
Line 42: | Line 48: | ||
==Sleep Medicine Program== | ==Sleep Medicine Program== | ||
* W8MD’s [[sleep medicine]] program provides state-of-the-art technology to diagnose and treat over 80 different sleep disorders, including [[sleep apnea]], [[narcolepsy]], [[restless legs syndrome]], and [[insomnia]]. With convenient home sleep studies or in-lab sleep diagnostic studies, patients can receive an accurate diagnosis and effective treatment. | * W8MD’s [[sleep medicine]] program provides state-of-the-art technology to diagnose and treat over 80 different sleep disorders, including [[sleep apnea]], [[narcolepsy]], [[restless legs syndrome]], and [[insomnia]]. With convenient home sleep studies or in-lab sleep diagnostic studies, patients can receive an accurate diagnosis and effective treatment. | ||
==Nutrition== | ==Nutrition== | ||
Line 51: | Line 55: | ||
|} | |} | ||
<h2 style="margin:0;background-color:#dfefdf;font-size:120%;font-weight:bold;border:1px solid #defbfa;text-align:left;color:#000;padding:0.2em 0.4em;">'''Weight loss news'''</h2> | <h2 style="margin:0;background-color:#dfefdf;font-size:120%;font-weight:bold;border:1px solid #defbfa;text-align:left;color:#000;padding:0.2em 0.4em;">'''Weight loss news'''</h2> | ||
In October 2022, the Food and Drug Administration (FDA) granted Mounjaro, a diabetes drug, a fast-track designation for weight loss, leading to speculation that it will be approved for weight loss use this year due to its promising results in clinical trials. | In October 2022, the Food and Drug Administration (FDA) granted Mounjaro, a diabetes drug, a fast-track designation for weight loss, leading to speculation that it will be approved for weight loss use this year due to its promising results in clinical trials. | ||
[[File:Weight-loss-success-stories.jpeg|thumb|Weight loss success stories]] | [[File:Weight-loss-success-stories.jpeg|thumb|Weight loss success stories]] | ||
[[File:W8md-protein-bar.jpeg|thumb|Weight loss supplements]] | [[File:W8md-protein-bar.jpeg|thumb|Weight loss supplements]] | ||
==3 things wrong with our diet== | ==3 things wrong with our diet== | ||
Line 72: | Line 72: | ||
* Many convenient locations | * Many convenient locations | ||
* New - Tele-visits after fist visit. [[W8md-advantage|Learn more...]] | * New - Tele-visits after fist visit. [[W8md-advantage|Learn more...]] | ||
=='''Amazing success stories'''== | =='''Amazing success stories'''== | ||
I started with Dr. Tumpati and W8MD in August 2014. I weighed 212 pounds. I am a five feet tall woman, at the time I was 56 years old. I was depressed, my cholesterol, blood pressure, and blood sugar were all elevated, and I was altogether miserable. At this writing, November 2019, I have lost and maintained 100 pounds. All my blood levels are now normal. I have energy, vitality, and if I say so myself, I look AMAZING! | I started with Dr. Tumpati and W8MD in August 2014. I weighed 212 pounds. I am a five feet tall woman, at the time I was 56 years old. I was depressed, my cholesterol, blood pressure, and blood sugar were all elevated, and I was altogether miserable. At this writing, November 2019, I have lost and maintained 100 pounds. All my blood levels are now normal. I have energy, vitality, and if I say so myself, I look AMAZING! | ||
Line 85: | Line 85: | ||
</blockquote> | </blockquote> | ||
[[File:Safe weight loss.jpg|Safe_weight_loss|500px|left]] | |||
I had struggled with my [[weight]] and the seemingly uncontrollable craving for inappropriate and/or excess food all my life. I am 65 years old, and had been obese since I was 3. | I had struggled with my [[weight]] and the seemingly uncontrollable craving for inappropriate and/or excess food all my life. I am 65 years old, and had been obese since I was 3. | ||
Latest revision as of 19:24, 30 June 2025
The W8MD' physician weight loss program is a clinically proven, evidence-based program that helps patients lose weight and maintain the weight with an ongoing maintenance plan for adults and children. Learn more...
Tirzepatide / Semaglutide for weight loss
Tirzepatide, available as Zepbound and Mounjaro, is a weekly injection that helps control blood sugar levels and was approved for use in treating type 2 diabetes by the FDA in May 2022. Distinguished from drugs such as Ozempic and Wegovy both of which have Semaglutide, Zepbound, Mounjaro with active ingredient of Tirzepatide is a combination of a glucagon-like peptide-1 (GLP-1) receptor agonist, used for diabetes and weight loss treatment, and a glucose-dependent insulinotropic polypeptide (GIP), a hormone that aids insulin release after eating.
Tirzepatide became so popular that it was listed by the FDA as one of nearly 200 drugs experiencing a supply shortage, along with Wegovy, Ozempic (semaglutide), and Trulicity (dulaglutide), which are sometimes prescribed for off-label weight loss use. Learn more...
|
Sleep issues?W8MD can help. Sleep Medicine Program
Nutrition
|
Weight loss news
In October 2022, the Food and Drug Administration (FDA) granted Mounjaro, a diabetes drug, a fast-track designation for weight loss, leading to speculation that it will be approved for weight loss use this year due to its promising results in clinical trials.
3 things wrong with our diet
“Let food be your medicine and medicine be your food” – Hippocrates According to the CDC, More than one-third of adults (35.7%) are obese defined as a body mass index(BMI) of 30 or more. Another third of all Americans are in the overweight category defined as those with a body mass index between 25-30 taking the total number of Obese and Overweight Americans to about 68% percent of the population. Almost 17% of youth were also obese. Learn about the 3 things wrong with our diet